QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oldfield, J. E. Search for Related Content PubMed PubMed Citation Articles by Oldfield, J. E.

The Two Faces of Selenium¹

Nutrition Research Institute, Oregon State University, Corvallis, OR 97331

The nutritionally important trace elements share a high biological activity, implemented through association with enzymes, hormones or vitamins. The same activity responsible for physiological responses at extremely low dietary levels implies the potential for metabolic upset when the elements are ingested at elevated, although still relatively low levels. Selenium provides a classic example of this dichotomy of effects and has generated concerns at both ends of its supply spectrum. Experiences in the Dakotas, mid-19th century, led to identification of toxicity symptoms for which selenium was later shown to be responsible, while separate studies showed that excess selenium was teratogenic in the developing avian fetus. These toxic reactions suggested that selenium might be useful in restricting abnormal cell growth, and recent studies have proved it to be anticarcinogenic in certain specific circumstances. Investigation of selenium's nutrient function has been equally interesting, and when Schwarz showed it to be an essential nutrient in 1957, he began an era of intense research activity. Dietary levels of selenium below 0.02 ppm were found to cause deficiency symptoms affecting muscles, liver and pancreas and glutathione peroxidase was shown to be an active form through which selenium acted to prevent such aberrations. Research continues to seek other active organic combinations for selenium to identify interfering compounds that restrict its bioactivity and to explore biochemical mechanisms involved in its toxicity.

KEY WORDS: • selenium • cancer • heart disease • glutathione peroxidase

¹ This review was adapted from a paper given by Dr. Oldfield to the 47th Annual Biology Colloquium at Oregon State University, May 2, 1986.

Manuscript received 14 July 1987. Revision accepted 31 August 1987.

This article has been cited by other articles:

				R L Bruhn, W D Stamer, L A Herrygers, J M Levine, and R J Noecker Relationship between glaucoma and selenium levels in plasma and aqueous humour Br J Ophthalmol, September 1, 2009; 93(9): 1155 - 1158. [Abstract] [Full Text] [PDF]

				D. Cherdwongcharoensuk, S. Upatham, J. C. Oliveira, A. Sousa Pereira, and A. P. Aguas Changes in Bronchoalveolar Lavage Cells after Intratracheal Instillation of Dimethyl Selenide in Mice Toxicol Pathol, April 1, 2004; 32(3): 345 - 350. [Abstract] [PDF]